Stock screenerAll disclosures →
EDGAR →
EDIT
Conviction 49HealthcareScan · Thu, Sep 24, 2026Editas Medicine, Inc. (EDIT) closed at $2.76 (+2.60%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 46, RS Rating 40, -33.5% from its 52-week high, +34.6% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
EDIT$2.76+2.60%
ResistanceSupportVol 14Insider sellVol MA14 3.81M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
WSB mentions · 24h changelatest +100.00%· 2 mentions
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price2.76
Change+2.60%
Gap-0.74%
Rel volume1.70×
Avg volume3.28M
Avg $ vol9.27M
SMA 202.89
SMA 502.87
SMA 2002.64
Price vs 50-3.77%
Price vs 200+4.69%
MA stackmixed
50/200 cross—
Supertrendup · 2.61
RSI (14)46
MACD hist-0.01
MACD cross—
Stoch %K / %D31 / 33
ADX (14)21
+DI / −DI27 / 17
RSI divergence—
MACD divergence—
ATR %7.54%
ADR %6.68%
52w high4.15
52w low1.67
From 52w high-33.49%
Above 52w low+65.77%
New 52w highNo
SqueezeOff
Bollinger width28.80%
%B0.34
Donchian pos24.86%
Donchian high3.41
Donchian low2.55
AVWAP (52w high)2.83
vs AVWAP high-2.38%
AVWAP (52w low)2.85
vs AVWAP low-3.11%
OBV trendFlat
Chaikin MF (20)-0.26
Today vs 20d1.70×
Avg vol (14d)3.81M
Avg vol (20d)3.28M
Avg $ vol (20d)9.27M
Market cap423.88M
RS Rating40 / 99
RS 3m (vs SPY)-3.76%
RS 6m (vs SPY)+2.15%
RS line new highNo
Trend template4/8
Technical rank56.6
1 week+1.47%
1 month-15.85%
3 months+0.73%
6 months+18.97%
1 year-8.31%
YTD+34.63%
P/E-2.65
P/B4.03
P/S10.46
P/FCF-2.56
EPS-1.80
Div yield—
ROE-152.03%
ROA-67.43%
Debt/Eq0.53
Current3.19
EV/EBITDA—
Gross margin—
Net margin-395.01%
Rev growth25.39%
EPS growth32.49%
Price target5.60
Target upside102.90%
Analyst ratingBuy
Institutional84.06%
Ent. value297.8M
Revenue11.89M
Net income-18.23M
Gross profit—
Free cash flow-165.85M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out97.91M
Employees87
ListedWed, Feb 3, 2016
Free float96.07M
Float %98.4%
Short interest30.23M
Days to cover9.0d
Short volume57.2%
Squeeze score87 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.15 vs −$0.30
Last surprise+50.0% beat
Setup gradeC
Conviction49 / 100
Pattern quality—
Tech rank56.6 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.41
Support2.56
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- CRSP, NTLA, BEAM, PRME, EDIT Shares Slip — Did Claude Just Spook Gene-Editing Stocks?Stocktwits · Wed, Sep 23, 2026
Congress activity
Disclosed STOCK Act trades in EDIT
No recent disclosed trades by Congress in EDIT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in EDIT · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Ory Daniel Scott EVP, Chief Medical Officer · Stock Option (right to buy) · 2026-09-08 | Grant | 950K | — | 2026-09-08 | 2026-09-09 |
Ellinor Patrick Thomas II Director · Stock Option (right to buy) · 2026-08-06 | Grant | 103.4K | — | 2026-08-06 | 2026-08-07 |
Parison Amy SVP, Chief Financial Officer · Common Stock · 2026-08-03 | Sell | 678 | $2K | 2026-08-03 | 2026-08-05 |
Connaughton Bernadette Director · Stock Option (right to buy) · 2026-06-17 | Grant | 51.7K | — | 2026-06-17 | 2026-06-22 |
Levy Elliott M. Director · Stock Option (right to buy) · 2026-06-17 | Grant | 51.7K | — | 2026-06-17 | 2026-06-22 |
Scadden David Director · Stock Option (right to buy) · 2026-06-17 | Grant | 51.7K | — | 2026-06-17 | 2026-06-22 |
Hirsch Andrew Director · Stock Option (right to buy) · 2026-06-17 | Grant | 51.7K | — | 2026-06-17 | 2026-06-22 |
Hopfield Jessica Director · Stock Option (right to buy) · 2026-06-17 | Grant | 51.7K | — | 2026-06-17 | 2026-06-22 |
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER · Common Stock · 2026-06-03 | Sell | 731 | $2K | 2026-06-03 | 2026-06-05 |
O'Neill Gilmore Neil CEO · Common Stock · 2026-06-03 | Sell | 15.38K | $42K | 2026-06-03 | 2026-06-05 |
SEC filings
EDGAR filings in EDIT · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.